NASHVILLE, Tenn.--(BUSINESS WIRE)-- PharmMD, the nation’s leader in quality Medication Therapy Management (MTM) services, applauds the January 9th report, Improving Patient and Health System Outcomes through Advanced Pharmacy Practice, from the Office of the Chief Pharmacist, U.S. Public Health Service.
With an official endorsement letter from Regina Benjamin, MD, MBA, U.S. Surgeon General, this report outlines four focus points that confirm the value and present the roadmap for integration of pharmacists more fully into the patient care process.
“On behalf of PharmMD and our pharmacist network, we are thankful to the U.S. Surgeon General’s letter and bringing this report to policy makers’ attention. As a pharmacist who is driven by patient care and the appropriate use of medications, I see more evidence to support pharmacist-provided MTM services than in any other level of health care. This report confirms the value pharmacists provide to the health care industry and the community at-large,” said Brad Tice, PharmD, FAPhA, Chief Clinical Officer of PharmMD.
Key points of the report:
Focus Point 1 of the report discusses how pharmacists are integrated into primary care as providers. It explains how pharmacists are involved in primary care within the Federal system and outside of the system through Collaborative Practice Agreements.
Focus Point 2 discusses the need for recognition of pharmacists as health care “providers” in legislation and policy, and demonstrates how pharmacists are being held back from providing the full benefits to patient care because of the barriers that exist in payment models.
Focus Point 3 describes the need for “provider” status of pharmacists and highlights the need for expansion of MTM services. Many eligibility limitations are noted in the report that warrant consideration. “MTM has made significant strides since it was introduced in the Medicare Part D benefit in 2006, but the report is right to call out the limitations introduced through the defined eligibility restrictions and current model,” said Tice.
Focus Point 4 provides the evidence for the value of pharmacist services. Through literature review it shows that the average benefit gained through pharmacist services over nearly two decades of research was $10.07 per $1 of allocated funds.
To read the full report and letter from Dr. Benjamin, go to A Report to the US Surgeon General 2011.
PharmMD is the quality leader in Medication Therapy Management (MTM) Solutions. Based in Brentwood, Tenn., PharmMD works with employers and health plans to prevent medication related health problems through the application of the best pharmacist and physician knowledge using innovative medication therapy technologies. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at: www.pharmmd.com.
Holly Flontek, 615-312-7072
KEYWORDS: United States North America Tennessee
INDUSTRY KEYWORDS: Practice Management Health Public Policy/Government Healthcare Reform Pharmaceutical Public Policy Managed Care